InvestorsHub Logo
Followers 829
Posts 119670
Boards Moderated 16
Alias Born 09/05/2002

Re: None

Tuesday, 11/05/2019 2:54:22 PM

Tuesday, November 05, 2019 2:54:22 PM

Post# of 625
ICPT 3Q19 results:

http://ir.interceptpharma.com/news-releases/news-release-details/intercept-pharmaceuticals-reports-third-quarter-2019-financial

ICPT raised full-year 2019 Ocaliva sales guidance (for PBC indication only) to $245-250M (from the prior range of $235-245M).

CC slides:
http://ir.interceptpharma.com/static-files/45a2334a-a7ae-4416-bb79-052be89a326e

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ICPT News